0.5 mg tirzepatide Zepbound 5 mg/0.5 mL injection (single-dose vial) Images Retatrutide vs tirzepatide dosage chart:

Metformin is a common medication that healthcare providers may recommend for managing Type 2 diabetes instead of (or in addition to) GLP-1 medications

For type 2 diabetes , NICE guideline NG28 recommends GLP-1 receptor agonists in specific circumstances, including: As part of triple therapy (with metformin and either a sulfonylurea or pioglitazone) when dual therapy with metformin and another oral drug has not achieved adequate glycaemic control As part of triple therapy with metformin and a sodium-glucose cotransporter 2 (SGLT2) inhibitor if certain criteria are met In combination with insulin, with or without other antidiabetic drugs Treatment should be continued only if there is a beneficial metabolic response (reduction of at least 11 mmol/mol in HbA1c and weight loss of at least 3% at 6 months)

This is where the concept of bioavailability becomes the most important factor in your decision-making process

Alternatively, free fatty acids bind to and activate their respective free fatty acid Lcell receptors, for example FFA1 (GPR40) and FFA4 (GPR120) to increase intracellular Ca 2+ via Gq signalling pathways that stimulate PKC signalling leading to GLP1 secretion (Tolhurst et al., 2011)